InvestorsHub Logo
icon url

ghmm

06/14/11 3:22 PM

#121629 RE: genisi #121353

UTHR:

We talked about some of this some time ago Matthew Herper put together a good summary of some of things Dr. Rothblatt has done. I think last years (or perhaps the year before) Dr. Rothblatt had a painting done where upper management was depicted in an operating room procedure of sorts (Frankly I don't know how to describe maybe Frankenstein does surgery would have been a good title)

http://blogs.forbes.com/matthewherper/2011/06/14/strangest-biotech-of-all-issues-annual-report-in-comic-book-form/

icon url

ghmm

07/28/11 9:39 AM

#124063 RE: genisi #121353

UTHR

On the call today they said the C2 results will be reported a bit early (late August) then previously announced. There was also a question if results are not positive would they still file and the answer was Yes. Dr. Jeffs indicated they are in the process now at working on the file.

On Tyvaso they said avg. patient time on therapy is over 16 months now (and increasing). I thought Results were better then I expected (though I don't keep as close an eye on results).

As an aside they mentioned they have 20-21 patients using an implantable pump (I think 19 were in Europe). I guess the main benefit is site pain along with the less administration (I seem to recall it being a very high concentration). Sounds pretty scarey to me though if something should go wrong and you get a bolus amount.